PF-00232798

· Pfizer

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for PF-00232798, covering 2010-12-23 to 2013-10-30. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Study Of PF-00232798 In HIV Positive Patients [Phase 2]